Interview with Gary Romano

What is your current role in EPAD? I am a member of the Executive committee, the CDEx clinical Mitterrand and balancing committee.   What did you do prior to joining EPAD? I have been working in neuroscience drug development for nearly 16 years, at Merck and at Janssen.      Tell us a bit about…

EPAD organises a cross-IMI Disease Modelling Workshop

On 16-18 October, the European Prevention of Alzheimer’s dementia (EPAD) project organised its first IMI-AD Platform Disease Modelling Workshop in Edinburgh, UK. The aim of the meeting was to bring together the modelling community within IMI funded projects to facilitate and encourage interactions between the overlapping communities. On the first day, the chair of the…

EPAD invited to speak at Alzheimer Europe Conference

A great occasion to get to know more on three Alzheimer’s Disease IMI (Innovative Medicines Initiative) projects, was at the 27th Alzheimer Europe Conference (#27AEC), held in Berlin from 2-4 October. At a symposium convened by Eli Lilly, entitled: “Engaging with patient organisations within IMI consortia to inform quality, relevance and value in Alzheimer’s research…

Farewell to Lennert Steukers

The EPAD family bids a fond farewell to Lennert Steukers. Lennert worked full time as project manager for Janssen on the IMI-EPAD project and provided the overall management to the project. In this role, he notably supported the coordinator, executive committee and the WP leaders in day-to-day management. He was also involved in EPAD’s internal…

EPAD project participates at the EFPIA Rentrée 2017

On 7 September, the European Federation of Pharmaceutical Industries and Associations (EFPIA) held an event under the banner “Unlocking tomorrow’s cures” in Brussels, Belgium. The EFPIA Rentrée 2017 gathered six scientists working on groundbreaking, innovative and life-changing therapies: Dr Frank Bähner, Area Head Prophylactic Vaccines at Curevac, explained the advantages of mRNA vaccines where pandemics…

EPAD is glad to be featured in The Times Scotland

On 31 July, The Times Scotland published an article entitled: “Everyday pill to stop dementia in its tracks is tested in Scotland” where the EPAD project was featured. In this great article wrote by Helen Puttick, the health reporter for The Times in Scotland, Prof Craig Ritchie, EPAD co-coordinator, explained dementia prevention and mentioned that…

Interview with Philip Hougaard

What is your current role in EPAD? I am a biostatistician and therefore my key role is in the statistical work package (WP2). I have mostly been involved in writing the protocol for the proof-of-concept study, which has been evolving since I joined EPAD in February 2016. WP2 is also responsible for statistical modelling of…